Soleil Securities initiates coverage on Gilead Science, Inc. (Nasdaq: GILD) with a Buy. Price target $58.

Soleil analyst says, "Focused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE